- Home
- SIBN
SIBN
SI-BONE Inc.
as 12-18-2024 11:42am EST
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 557.9M | IPO Year: | 2018 |
| Target Price: | $23.43 | AVG Volume (30 days): | 250.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.91 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.70 - $21.70 | Next Earning Date: | 11-12-2024 |
| Revenue: | $157,035,000 | Revenue Growth: | 18.98% |
| Revenue Growth (this year): | 21.24% | Revenue Growth (next year): | 15.59% |
Stock Insider Trading Activity of SI-BONE Inc. (SIBN)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Nov 18 '24 | Sell | $12.57 | 6,007 | $74,803.27 | 228,554 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Nov 18 '24 | Sell | $12.68 | 2,439 | $30,936.60 | 194,623 | |
| DUNN JEFFREY W | SIBN | Director | Nov 18 '24 | Sell | $12.43 | 1,609 | $20,001.32 | 20,431 | |
| FRANCIS LAURA | SIBN | Chief Executive Officer | Nov 18 '24 | Sell | $12.59 | 10,048 | $126,353.69 | 491,881 | |
| DUNN JEFFREY W | SIBN | Director | Nov 4 '24 | Sell | $13.55 | 341 | $4,620.55 | 20,431 | |
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Oct 2 '24 | Sell | $13.59 | 4,226 | $57,402.83 | 228,554 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Oct 2 '24 | Sell | $13.58 | 3,305 | $44,886.32 | 194,623 |
Latest SI-BONE Inc. News
SIBN Breaking Stock News: Dive into SIBN Ticker-Specific Updates for Smart Investing
Zacks
6 days ago
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.71%: Here's is How to Trade
Zacks
22 days ago
Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?
GlobeNewswire
a month ago
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
Simply Wall St.
a month ago
SI-BONE, Inc. (NASDAQ:SIBN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think
Simply Wall St.
a month ago
SI-BONE Third Quarter 2024 Earnings: EPS Beats Expectations
Thomson Reuters StreetEvents
a month ago
Q3 2024 SI-BONE Inc Earnings Call
GuruFocus.com
a month ago
SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Revenue and Path to Profitability
Zacks
a month ago
Si-Bone (SIBN) Reports Q3 Loss, Lags Revenue Estimates
Compare SIBN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SIBN SI-BONE Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.